Skip to content
MedsAcross

Medicine

Imipramine 50 mg tablet

Imipramine · Oral
Available on requestPrescription onlyUS FDAGeneric name

Imipramine 50 mg tablet is a generic prescription medicine for oral use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store between 15° to 25°C (59° to 77°F).

Key facts

Active ingredient (INN)
Imipramine
Brand
Sold under the generic name
Strength
50 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 1000 tablets, 90 tablets and 15 more
Manufacturers
Strides PharmaIndiaProficient RxPD-Rx PharmaceuticalsLeading PharmaOxford PharmaceuticalsNuCare Pharmaceuticals,IncRemedyrepack8 labelers on the register
Origin register
US FDA, United States
Storage
Store between 15° to 25°C (59° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N06AA02 Imipramine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
21 December 2010
Identifiers
RxCUI 835564, 835568, 835593DailyMed set ID 51d3b181-0d15-4782-a966-feb137972b18, 7091ff32-55b9-48fd-a86d-c502af57473f, 55311747-710c-43c4-821d-76323ff2520e +6NDC 64380-171, 72789-493, 68180-313 +6Application ANDA088276, ANDA040903, ANDA090441 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle, plastic64380-171-01Strides PharmaIndia11 April 2022
1000 tablet in 1 bottle, plastic64380-171-02Strides PharmaIndia11 April 2022
100 tablet, film coated in 1 bottle69315-135-01Leading Pharma12 December 2025
1000 tablet, film coated in 1 bottle69315-135-10Leading Pharma1 May 2016
100 tablet in 1 bottle69584-427-10Oxford Pharmaceuticals1 August 2020
1000 tablet in 1 bottle69584-427-90Oxford Pharmaceuticals15 May 2022
100 tablet in 1 bottle, plastic72789-244-01PD-Rx Pharmaceuticals14 April 2022
100 tablet, film coated in 1 bottle, plastic72789-493-01PD-Rx Pharmaceuticals3 September 2025
1000 tablet, film coated in 1 bottle, plastic72789-493-95PD-Rx Pharmaceuticals3 September 2025
90 tablet in 1 bottle68071-3669-9NuCare Pharmaceuticals1 August 2020
100 tablet in 1 bottle82804-958-00Proficient Rx12 January 2026
1000 tablet in 1 bottle82804-958-11Proficient Rx12 January 2026
30 tablet in 1 bottle82804-958-30Proficient Rx12 January 2026
500 tablet in 1 bottle82804-958-55Proficient Rx12 January 2026
60 tablet in 1 bottle82804-958-60Proficient Rx12 January 2026
120 tablet in 1 bottle82804-958-72Proficient Rx12 January 2026
90 tablet in 1 bottle82804-958-90Proficient Rx12 January 2026
30 tablet, film coated in 1 blister pack70518-1588-0Remedyrepack25 October 2018

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 16 April 1959Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Imipramine

Clinical summary

Imipramine is a tricyclic antidepressant. It is available as tablets and capsules for oral use. MedsAcross supplies Imipramine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Imipramine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Imipramine 50 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.